Antibiotics have been the savior of modern medicine, saving countless lives. However, their overuse has led to a rise in antibiotic-resistant bacteria, also known as superbugs. With no cure in sight, the threat of antimicrobial resistance is projected to cause ten million deaths annually by 2050. The search for new antibiotics has been slow, with the rate of resistance increasing rapidly. However, a revolutionary new treatment offers a glimmer of hope.
Bacteriophage Therapy
The state of Georgia, in the former Soviet Union, has been researching bacteriophage therapy for decades. While Western countries focused on the discovery of new antibiotics, research continued in Georgia, leading to the development of bacteriophage therapy. Using viruses to neutralize bacteriophage bacteria, bacteriophage therapy offers a new approach to treating antibiotic-resistant infections. The Eliava Institute in Tbilisi, Georgia, uses bacteriophages as live antibiotics to treat patients from over 80 countries, with more than 500 foreign patients seeking treatment every year.
Bacteriophage Therapy Goes Global
Now, Western countries have intensified research into bacteriophage therapy. Companies and universities in the US, Belgium, Norway, and Denmark are leading the charge. Danish company Sniperbiome has completed trials of an E. coli infection drug, while Fagus is being used in fish farming in Norway. The US Food and Drug Administration has urged companies to speed up trials, recognizing the potential of bacteriophage therapy to combat antimicrobial resistance.
While the discovery of a new class of antibiotics has not occurred in the last 40 years, bacteriophage therapy offers a promising solution to the growing threat of antibiotic
resistance. As research into this innovative treatment continues, there is hope that we can combat superbugs and save millions of lives.
Also Read: Govt Sketching New Policy in Pharma Sector for Research and Innovation Via Centres of Excellence
